title: Interaction with cyclin H/cyclin-dependent kinase 7 (CCNH/CDK7) stabilizes C-terminal binding protein 2 (CtBP2) and promotes cancer cell migration.
abstract: CtBP2 has been demonstrated to possess tumor-promoting capacities by virtue of up-regulating epithelial-mesenchymal transition (EMT) and down-regulating apoptosis in cancer cells. As a result, cellular CtBP2 levels are considered a key factor determining the outcome of oncogenic transformation. How pro-tumorigenic and anti-tumorigenic factors compete for fine-tuning CtBP2 levels is incompletely understood. Here we report that the cyclin H/cyclin-dependent kinase 7 (CCNH/CDK7) complex interacted with CtBP2 in vivo and in vitro. Depletion of either CCNH or CDK7 decreased CtBP2 protein levels by accelerating proteasome-dependent CtBP2 clearance. Further analysis revealed that CCNH/CDK7 competed with the tumor repressor HIPK2 for CtBP2 binding and consequently inhibited phosphorylation and dimerization of CtBP2. Phosphorylation-defective CtBP2 interacted more strongly with CCNH/CDK7 and was more resistant to degradation. Finally, overexpression of CtBP2 increased whereas depletion of CtBP2 dampened the invasive and migratory potential of breast cancer cells. CtBP2 promoted the invasion and migration of breast cancer cells in a CCNH-dependent manner. Taken together, our data have delineated a novel pathway that regulates CtBP2 stability, suggesting that targeting the CCNH/CDK7-CtBP2 axis may yield a viable anti-tumor strategy.
authors: Department of Pathogen and Immunology, Medical College, Nantong University, Nantong 226001, China.
authors: Yuchan
authors: Y
authors: Wang
authors: Fang
authors: F
authors: Liu
authors: Feng
authors: F
authors: Mao
authors: Qinlei
authors: Q
authors: Hang
authors: Xiaodong
authors: X
authors: Huang
authors: Song
authors: S
authors: He
authors: Yingying
authors: Y
authors: Wang
authors: Chun
authors: C
authors: Cheng
authors: Huijie
authors: H
authors: Wang
authors: Guangfei
authors: G
authors: Xu
authors: Tianyi
authors: T
authors: Zhang
authors: Aiguo
authors: A
authors: Shen
mesh_terms: D000429:Alcohol Oxidoreductases / Q000378:metabolism*; D045744:Cell Line, Tumor; D002465:Cell Movement; D056970:Co-Repressor Proteins; D018844:Cyclin-Dependent Kinases / Q000378:metabolism*; D003513:Cycloheximide / Q000494:pharmacology; D015972:Gene Expression Regulation, Neoplastic; D057809:HEK293 Cells; D006801:Humans; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000378:metabolism*; D009419:Nerve Tissue Proteins / Q000378:metabolism*; D046988:Proteasome Endopeptidase Complex / Q000378:metabolism; D011485:Protein Binding; D025941:Protein Interaction Mapping; D017434:Protein Structure, Tertiary; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D014162:Transfection; D000095043:Cyclin-Dependent Kinase-Activating Kinase
chemical_list: D056970:Co-Repressor Proteins; D009419:Nerve Tissue Proteins; D011500:Protein Synthesis Inhibitors; D003513:Cycloheximide; D000429:Alcohol Oxidoreductases; C421248:CTBP2 protein, human; D018844:Cyclin-Dependent Kinases; D046988:Proteasome Endopeptidase Complex; D000095043:Cyclin-Dependent Kinase-Activating Kinase; C000722416:CDK7 protein, human
references: J Biol Chem. 2006 Feb 17;281(7):4183-9
references: 16356938
references: Lancet. 2007 May 19;369(9574):1742-57
references: 17512859
references: Oncogene. 2000 Aug 3;19(33):3823-8
references: 10949939
references: Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9029-33
references: 16740659
references: Int J Cancer. 2006 Nov 1;119(9):2098-104
references: 16804902
references: J Biol Chem. 2005 Apr 29;280(17):17163-71
references: 15734731
references: Oncogene. 2003 Sep 29;22(42):6524-36
references: 14528277
references: Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9574-9
references: 10449734
references: Int J Cancer. 2011 Nov 15;129(10):2310-4
references: 21792896
references: Oncogene. 2005 Aug 29;24(37):5764-74
references: 16123809
references: Int J Gynecol Cancer. 2006 Jan-Feb;16(1):402-8
references: 16445666
references: Cancer Res. 2009 Feb 1;69(3):731-4
references: 19155295
references: Eur J Cancer. 2010 Jan;46(1):170-9
references: 19926475
references: Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3775-80
references: 16537454
references: Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2802-7
references: 15708980
references: Nat Genet. 2008 Mar;40(3):310-5
references: 18264096
references: Am J Epidemiol. 2012 May 1;175(9):926-35
references: 22459122
references: Mol Cell Biol. 2011 Mar;31(5):955-70
references: 21199918
references: Mol Cell Biol. 2006 Jul;26(13):4882-94
references: 16782877
references: Histol Histopathol. 2004 Jan;19(1):173-88
references: 14702186
references: Annu Rev Cell Dev Biol. 2011;27:347-76
references: 21740232
references: Biol Cell. 2010 Jan;103(1):1-19
references: 20964627
references: Cell Cycle. 2010 Sep 15;9(18):3740-50
references: 20930544
references: Oncogene. 2013 Aug 15;32(33):3896-903
references: 22945647
references: Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14323-8
references: 11114158
references: BMC Cell Biol. 2006 Sep 25;7:35
references: 16999872
references: Mol Cell. 2002 Feb;9(2):213-24
references: 11864595
references: EMBO J. 2011 May 18;30(10):2031-43
references: 21468031
references: Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4568-73
references: 12676992